Article info
Research
Pancreatic enzyme replacement therapy (PERT) for malabsorption in patients with metastatic pancreatic cancer
- Correspondence to Dr Amanda Landers, Hospice Palliative Care Service, Nurse Maude Association, P O Box 36-126, Christchurch 8146, New Zealand; Amanda.Landers{at}nursemaude.org.nz
Citation
Pancreatic enzyme replacement therapy (PERT) for malabsorption in patients with metastatic pancreatic cancer
Publication history
- Received April 22, 2014
- Revision received June 23, 2014
- Accepted August 13, 2014
- First published August 27, 2014.
Online issue publication
April 19, 2016
Article Versions
- Previous version (19 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/